New treatment protocol for advanced head and neck cancer
‘Our unique ability to generate pre-clinical HNC models and to investigate new treatment and treatment combinations provides hope for HNC patients.’
‘Our unique ability to generate pre-clinical HNC models and to investigate new treatment and treatment combinations provides hope for HNC patients.’
Cannabotech’s idea is not to replace existing cancer treatments but to enable a patient to have fewer treatments with the same benefit.
A research group analyzes why cancer spread can be triggered by successful chemotherapy and suggests how to prevent it.
New Phase nanotech company aims to transform end-stage cancer from a likely death sentence to a chronic illness.
Israeli oncologist and neuroscientist collaborate on multisensory gadgets to enhance hope and wellbeing for cancer patients, families and staff.
Study shows that single short peptides have an important role as a kinase inhibitor that can slow tumor growth and metastasis.
Researchers have developed an immunotherapy platform that inhibits melanoma using TRAIL proteins and NanoGhost technology as a drug-delivery vehicle.
When a family member is diagnosed with cancer, healthy kids often suffer from the fallout. Now an organization aims to bring the fun back into their lives.
Study finds certain immune cells sometimes ‘switch sides’ and actually help tumors grow; finding has implications for improving immunotherapy
Study suggests the possibility of ‘off-the-shelf’ immunotherapies in which T cell receptors that recognize cancer hotspots can be prepared in advance.
Yonatan Winetraub shifted his focus from outer space to the human body. At Stanford University, he is working on detecting cancer without biopsies.
New study shows eosinophils can be summoned to fight cancer by destroying the cancer cells directly and by recruiting T-cells to help.
A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies.
Nectin Therapeutics creates a roadblock to stop cancer cells evading immunotherapy treatments, boosting the success of the therapy.
With the immune system, what we don’t know far outweighs what we do. An Israeli startup aims to fill in those all-important gaps.